These final results, together with a former report displaying that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like conduct in mice,2 aid the strategy of focusing on ACKR3 as a unique approach to modulate the opioid method, which could open new therapeutic avenues for opioid-similar Conditions.Gene expression Examination exposed that